Dana Farber Cancer Institute The Melanoma Program

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Cushing's Disease

Studies at this site

• Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease — Completed